Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth in/Near Infected Bone Cavities
Elute, Inc. · NCT05361941
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 22+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 204
- US sites recruiting
- 12
- Study start
- August 31, 2023
- Record last updated
- July 14, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is a pivotal, prospective, multi-center, randomized, concurrent control, patient and assessor-blinded study with two arms: a treatment arm (where subjects will be treated with the EP Granules + Tobramycin (EP G + T) investigational device, a combination device + antibiotic, in the 1st stage of a staged revision for periprosthetic joint infection (PJIs), and a control arm (where subjects are treated with the standard-of-care revision for infected PJIs).
Being studied: EP Granules with Tobramycin; empty voids
Conditions: Periprosthetic Joint Infections
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Ages and sexes eligible: at least 22 years, male and female
- Candidates with known infected TKA
- Life expectancy of at least 1 year
- Patient is willing to provide informed consent, is geographically stable and able to comply with the required follow up visits, testing schedule and medication regimen
- Adequate soft tissue coverage
- Signed institutional review board approved informed consent
Exclusion Criteria
- Severe renal impairment with eGFR \<50 ml/min/1.73 m2, or being treated with dialysis
- Known hypersensitivity to aminoglycoside antibiotics, or calcium hydroxyapatite
- Pre-existing calcium metabolism disorder
- Uncontrolled diabetes mellitus (hemoglobin A1c levels > 8)
- A current endocrine or metabolic disorder known to affect osteogenesis (e.g., Paget's disease, renal osteodystrophy, hyperthyroid parathyroid hormone disorder, Ehler- Danlos syndrome, osteogenesis imperfecta)
- Neuromuscular disorders such as myasthenia gravis
- Untreated malignant neoplasm(s), or currently undergoing radiation chemotherapy
- Inadequate neurovascular status in the involved limb that may jeopardize healing
- HIV
- Pregnancy
- Adult patients requiring a legal guardian to sign informed consent form
Recruiting US locations
University of Southern California
Los Angeles, CA 90033
Site contact: Pui Yan · puiyan@med.usc.edu
Georgetown University Medical Center
Washington D.C., DC 20007
Site contact: Joshua Lawrence · 240-863-1681 · joshua.lawrence@medstar.net
Endeavor Health Skokie Hospital
Skokie, IL 60076
Site contact: John Carroll · 847-933-6328 · jcarroll@northshore.org
OrthoIndy
Indianapolis, IN 46278
Site contact: Melanie Glover · 317-802-2880 · mglover@orthoindy.com
Sinai Hospital
Baltimore, MD 21215
Site contact: Makayla Crosby · 410-601-2663 · mcrosby@lifebridgehealth.org
U Michigan Medical Center
Ann Arbor, MI 48109
Site contact: Justin Quimbo · 734-232-4145 · quimbo@med.umich.edu
Hospital for Special Surgery
New York, NY 10021
Site contact: Amar Ranawat, MD · 212-606-1000 · ranawatamar@hss.edu
OrthoCarolina
Charlotte, NC 28204
Site contact: Justin Norwood · 704-323-3845 · justin.norwood@orthocarolina.com
JIS Orthopedics
Columbus, OH 43054
Site contact: Michael Sneller · 614-964-0348 · snellerma@jisortho.com
Carrollton regional Medical Center
Carrollton, TX 75010
Site contact: Angela Mealing · 469-443-0924 · mealing@dallaslimbrestoration.com
UT Health San Antonio
San Antonio, TX 78229
Site contact: Jhemima Rizalde · 210-567-6176 · rizalde@uthscsa.edu
Jordan Valley Medical Center
West Jordan, UT 84088
Site contact: David Evans, MD · (801) 891-5056 · dcevans1@gmail.com
Study contacts (from the official record)
- Ashok Khandkar, PhD · 801-410-4330 · ak@elutinc.com
- Eva Serio, BS · 801-410-4330 · eva@elutinc.com
Similar studies in California
All healthy volunteers studies in California →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- Rialto, CA + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Lake Forest, CA + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Phase 1 Study of SBS-147 in Healthy Adults
Sparian Biosciences, Inc
- Location
- Cypress, CA
- Eligibility basics
- Ages 18–55